Mirum Pharmaceuticals, Inc. (MIRM) Stock Total Returns
Growth of $10,000 chart
2021-04-14 to 2026-04-14 to
$
%
%
Loading chart…
Investment Performance
Final Value
$51,985
Total Return
419.85%
CAGR
39.06%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +3.69% |
| Median | +1.99% |
| Best | +50.53% |
| Worst | -29.75% |
| % of Windows Positive | 54.8% |
1-Year (252 Trading Days)
| Average | +43.93% |
| Median | +40.48% |
| Best | +147.70% |
| Worst | -14.38% |
| % of Windows Positive | 93.3% |
3-Year (756 Trading Days)
| Average | +173.30% |
| Median | +163.75% |
| Best | +379.59% |
| Worst | +26.37% |
| % of Windows Positive | 100.0% |
Risk Metrics
| Maximum Drawdown | -40.25% |
| Average Drawdown | -13.89% |
| Drawdown Duration | 214 Trading Days |
| Sortino Ratio | 1.36 |
| Calmar Ratio | 0.97 |
| CVaR (5%) | -7.07% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +22.67% (+104.97% ann.) | +$2267.38 | $0.00 | $0.00 | $0.00 |
| 2025 | +91.03% | +$9102.78 | $0.00 | $0.00 | $0.00 |
| 2024 | +40.07% | +$4007.45 | $0.00 | $0.00 | $0.00 |
| 2023 | +51.38% | +$5138.47 | $0.00 | $0.00 | $0.00 |
| 2022 | +22.26% | +$2225.70 | $0.00 | $0.00 | $0.00 |
| 2021 | -8.65% | $864.83 | $0.00 | $0.00 | $0.00 |
| 2020 | -28.79% | $2879.28 | $0.00 | $0.00 | $0.00 |
| 2019 partial | +85.62% (+289.98% ann.) | +$8561.70 | $0.00 | $0.00 | $0.00 |
Market Regimes
| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | July 18, 2019 – February 19, 2020 | +36.94% | +70.17% | +$3694.17 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -36.05% | -99.39% | $3605.41 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +44.63% | +81.08% | +$4463.27 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -28.81% | -27.55% | $2880.52 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | +40.69% | +43.69% | +$4068.88 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +100.85% | +45.68% | +$10084.74 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 14, 2026 | +155.67% | +81.92% | +$15567.28 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.